ENCell Co., Ltd. (KOSDAQ:456070)
16,140
-320 (-1.94%)
Apr 29, 2026, 11:50 AM KST
ENCell Market Cap
ENCell has a market cap or net worth of 181.08 billion as of April 28, 2026. Its market cap has increased by 16.41% in one year.
Market Cap
181.08B
Enterprise Value
155.59B
Revenue
5.26B
Ranking
n/a
PE Ratio
n/a
Stock Price
16,140.00
Market Cap Chart
Since August 23, 2024, ENCell's market cap has increased from 160.82B to 181.08B, an increase of 12.60%. That is a compound annual growth rate of 7.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 181.08B | -8.78% |
| Dec 30, 2025 | 198.50B | 7.25% |
| Dec 30, 2024 | 185.09B | 15.09% |
| Aug 23, 2024 | 160.82B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bioneer | 281.33B |
| EASY BIO,Inc. | 261.68B |
| JETEMA, | 260.84B |
| Genexine | 259.69B |
| MedPacto | 188.17B |
| Macrogen | 183.22B |
| Vaxcell-Bio Therapeutics | 178.38B |
| Amicogen | 133.16B |